Stuttering: Clinical Trials

1 trial for Stuttering, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Stuttering: new trials by email Literature Review of Stuttering trials Research Report on Stuttering

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
Ecopipam 50mg, Ecopipam 100mg - Stuttering, Adult, Childhood-onset Fluency Disorder
Phase 2 / Phase 3UnknownGerald Maguire, MD102016-09-012016-10-26

Narrower conditions

Childhood-Onset Fluency Disorder (1)  ·  Communication Disorders (1)  ·  Language Disorders (1)  ·  Speech Disorders (1)

Broader conditions

Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurodevelopmental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

ecopipam (1)

Sponsors

Gerald Maguire, MD (1)

Countries

United States (1)

Results publications

PMID 10917410, PMID 12849360, PMID 15026214, PMID 15212606, PMID 15328899, PMID 20075648, PMID 24434529